<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AParticipations</id>
	<title>Definition:Participations - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AParticipations"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Participations&amp;action=history"/>
	<updated>2026-05-01T07:09:47Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Participations&amp;diff=19308&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Participations&amp;diff=19308&amp;oldid=prev"/>
		<updated>2026-03-16T11:31:46Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏛️ &amp;#039;&amp;#039;&amp;#039;Participations&amp;#039;&amp;#039;&amp;#039; in the insurance context refers to ownership stakes or equity interests that an [[Definition:Insurance carrier | insurer]] or insurance group holds in other entities — whether those are other insurers, [[Definition:Reinsurance | reinsurers]], financial institutions, or non-financial companies. Under [[Definition:Solvency II | Solvency II]] and related regulatory frameworks, participations carry specific significance because they affect how an insurer&amp;#039;s [[Definition:Own funds | own funds]] and [[Definition:Solvency capital requirement (SCR) | capital requirements]] are calculated. A participation is typically distinguished from a simple financial investment by the degree of influence the holder exercises: regulatory definitions often set thresholds (commonly 20% or more of voting rights, or the exercise of significant influence) that trigger classification as a participation rather than a portfolio investment.&lt;br /&gt;
&lt;br /&gt;
⚙️ The treatment of participations in [[Definition:Regulatory capital | regulatory capital]] calculations varies by jurisdiction and by the nature of the entity in which the stake is held. Under Solvency II, participations in related insurance and financial undertakings are generally valued using the adjusted equity method or, in certain cases, a deduction-and-aggregation approach, rather than simply being marked to market alongside a portfolio of traded equities. This matters because the capital charge applied to a participation in a subsidiary insurer differs from the charge on a listed equity holding; the framework aims to avoid double-counting capital across group entities while ensuring the parent cannot artificially inflate its solvency position. For insurance groups operating across borders — common among large European groups such as [[Definition:Allianz | Allianz]] or [[Definition:Zurich Insurance Group | Zurich]] — the proper treatment of participations in subsidiaries and joint ventures is central to group-level solvency reporting. In jurisdictions outside Europe, similar principles apply: [[Definition:International Association of Insurance Supervisors (IAIS) | IAIS]] standards and frameworks like [[Definition:C-ROSS | China&amp;#039;s C-ROSS]] address the capital treatment of inter-company equity holdings, though specific thresholds and valuation methods vary.&lt;br /&gt;
&lt;br /&gt;
📌 Getting the classification and valuation of participations right has material consequences for an insurer&amp;#039;s reported capital strength and strategic flexibility. An insurer that holds significant participations in non-insurance financial entities — a bank or an [[Definition:Asset management | asset management]] firm, for example — may face additional capital charges or supervisory scrutiny, particularly under financial conglomerate regulations. Conversely, participations in insurance subsidiaries can sometimes be treated more favorably within group supervision, reflecting the regulated nature of both the parent and the subsidiary. For [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] activity in the insurance sector, the capital impact of acquiring a participation is a key factor in deal structuring: a stake just below or above the regulatory threshold can produce meaningfully different outcomes for group solvency ratios. Investors and analysts monitoring insurance group balance sheets pay close attention to the participations line, as it reveals the group&amp;#039;s structural complexity and the extent to which capital is deployed in controlled or affiliated entities rather than in liquid, easily redeployable assets.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Own funds]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Group supervision]]&lt;br /&gt;
* [[Definition:Financial conglomerate]]&lt;br /&gt;
* [[Definition:Equity risk sub-module]]&lt;br /&gt;
* [[Definition:Related undertaking]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>